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Abstract
Introduction: Our purpose was to study whether the time to target temperature correlates with neurologic
outcome in patients after cardiac arrest with restoration of spontaneous circulation treated with therapeutic mild
hypothermia in an academic emergency department.
Methods: Temperature data between April 1995 and June 2008 were collected from 588 patients and analyzed in
a retrospective cohort study by observers blinded to outcome. The time needed to achieve an esophageal
temperature of less than 34°C was recorded. Survival and neurological outcomes were determined within six
months after cardiac arrest.
Results: The median time from restoration of spontaneous circulation to reaching a temperature of less than 34°C
was 209 minutes (interquartile range [IQR]: 130-302) in patients with favorable neurological outcomes compared to
158 min (IQR: 101-230) (P < 0.01) in patients with unfavorable neurological outcomes. The adjusted odds ratio for a
favorable neurological outcome with a longer time to target temperature was 1.86 (95% CI 1.03 to 3.38, P = 0.04).
Conclusions: In comatose cardiac arrest patients treated with therapeutic hypothermia after return of spontaneous
circulation, a faster decline in body temperature to the 34°C target appears to predict an unfavorable neurologic
outcome.
Introduction
For patients who have been successfully resuscitated
after cardiac arrest, therapeutic mild hypothermia
increases the rate of a favorable outcome in comparison
with standard life support. Randomized controlled trials,
however, have not shown evidence of whether the time
to target temperature correlates with neurological out-
come [1-4]. Registries about the practical use of thera-
peutic hypothermia have also not found a significant
association between the timing of therapeutic hypother-
mia and final outcome [5-7]. We expected a strong rela-
tionship between the time to target temperature (<34°C)
and neurological outcome. Furthermore, we hypothe-
sized that earlier achievement of target temperature
would not necessarily improve outcome.
Materials and methods
The study was designed as a single-center retrospective
cohort study on temperature data extracted from
patients’ charts by observers blinded to outcome. The
protocol and consent procedures were approved by the
ethics committee of the Medical University of Vienna
and were performed in accordance with the Declaration
of Helsinki. This trial qualified for exception from
informed consent requirements for emergency research
as outlined in the applicable national laws of Austria.
The subjects enrolled were in an immediate life-
threatening situation, unconscious, and unable to pro-
vide consent for trial enrollment and had a mortality
approaching 75%. As cardiac arrest is frequently the first
manifestation of cardiovascular disease, there was no
way to prospectively identify individuals who would
become eligible for this trial. However, investigators
attempted to notify family members that the subjects
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competent during the trial period, he or she was
approached as soon as feasible by research personnel for
notification of enrollment. Data were collected at the
Department of Emergency Medicine of the Medical
University in Vienna between April 1995 and June 2008
and included data of reports on the same patients
[1,8-12] but did not include data focusing on the details
of the time to target temperature (Table 1). Participants
were consecutive emergency department patients after
cardiac arrest in whom spontaneous circulation had
been restored and who were receiving therapeutic
hypothermia with intensive care in accordance with a
standardized protocol [8,13,14].
Neurologic morbidity (a) and mortality (b) were inde-
pendently compared with the time to target tempera-
ture. Neurologic outcome was measured as a Pittsburgh
cerebral performance category (CPC) on a five-category
scale [15,16]. Patients with good recovery or moderate
disability had sufficient cerebral function to live
independently and work at least part-time (best CPC
1-2). The Pittsburgh CPCs were assessed on a regular
basis by means of structured patient interviews.
The temperature immediately on admission was mea-
sured with an infrared tympanic thermometer (Ototemp
LighTouch; Exergen Corporation, Watertown, MA,
USA). Continuous temperature measurements were
made as soon as possible in the commencement of
therapeutic cooling with a bladder-temperature probe
(Foley catheter temperature sensor; Smiths Medical,
Dublin, OH, USA) and with a general-purpose tempera-
ture probe (Mon-a-therm General purpose; Mallinckrodt
Medical Inc., now part of Covidien, Hazelwood, MO,
USA) inserted in the esophagus. Temperature-monitor-
ing data were extracted from patient charts by two inde-
pendently operating staff members. Temperature
recordings in the tympanum, esophagus, and bladder
were registered with regard to when the first measure-
ment after restoration of spontaneous circulation was
available: at the start of cooling and at the first
Table 1 Characteristics of patients in the study
Time to target temperature
<120 minutes 120 to 220 minutes >220 minutes P value
Age, years 56 (45-67) 60 (51-71) 58 (49-66) 0.34
Male 40 (65%) 48 (67%) 59 (82%) 0.05
Height, cm 175 (165-180) 175 (165-180) 177 (171-180) 0.01
Weight, kg 78 (70-85) 80 (71-90) 85 (75-95) 0.002
Cardiac arrest
Out-of-hospital 60 (97%) 64 (89%) 67 (93%) 0.21
Cardiac etiology 40 (65%) 54 (75%) 57 (79%) 0.15
Witnessed 53 (85%) 66 (92%) 63 (88%) 0.52
Bystander BLS
a 24 (39%) 20 (28%) 16 (22%) 0.10
1st ECG, VF/VT
b 34 (55%) 46 (64%) 52 (72%) 0.11
Defibrillations 2 (0-3) 2 (1-5) 2 (1-5) 0.55
Adrenaline, mg 3 (1-4) 2 (1-4) 3 (1-4) 0.58
No-flow
c, minutes 3 (1-10) 3 (0-7) 5 (1-8) 0.51
Low-flow
d, minutes 20 (14-27) 16 (10-22) 11 (9-23) 0.02
ROSC to admission, minutes 31 (25-42) 36 (24-54) 39 (26-51) 0.25
ROSC to cool, minutes 58 (29-72) 101 (58-130) 86 (43-130) 0.001
ROSC to awakening
e, days 5 (3-9) 4 (2-6) 4 (3-7) 0.59
ROSC to discharge, days 27 (17-51) 30 (20-46) 28 (21-45) 0.85
ROSC to death, days 7 (3-14) 6 (3-30) 18 (6-83) 0.05
Best CPC
f 4 (1-4) 3 (1-4) 1 (1-4) 0.006
Favorable neurologic outcome 23 (37%) 34 (47%) 45 (63%) 0.01
Survivors 30 (48%) 36 (50%) 40 (56%) 0.68
Temperature data between April 1995 and June 2008 were collected from 588 patients. The best cerebral performance category (CPC) achieved within 6 months
after cardiac arrest was used; this was not available in 17 patients who died during anesthesia. Data are presented as median (interquartile range) and as number
(percentage). The Kruskal-Wallis test for continuous data and chi-square test for categorical data were used to compare variables between the surviving and
dead groups and between the favorable and unfavorable neurologic outcome (CPC 1-2 versus 3-4) groups.
aPatients who have received basic life support from a
bystander.
bCardiac arrest with ventricular fibrillation or nonperfusing ventricular tachycardia as the initial cardiac rhythm on electrocardiogram.
cCardiac arrest
with no blood flow.
dInterval from the first attempt at resuscitation to restoration of spontaneous circulation (ROSC).
eAwakening was defined as response to
external stimuli with purposeful movements.
fA CPC of 1 indicates good cerebral performance (the patient is alert and has normal cerebral function). A CPC of 2
indicates moderate disability (the patient is alert and has sufficient cerebral function to live independently and work part-time). Such patients might have
hemiplegia, seizures, ataxia, dysarthria, dysphasia, or permanent memory loss, or other mental changes. A CPC of 3 indicates severe cerebral disability (the
patient is conscious but dependent on others for daily support because of impaired brain function). A CPC of 4 indicates a vegetative state.
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(Tables 2 and 3). Data on cardiac arrest for individual
patients were recorded in a database according to the
Utstein style [15,16].
T h ee x p o s u r eo fi n t e r e s tw a st h et i m en e e d e df r o m
restoration of spontaneous circulation to achieve a tem-
perature of less than 34°C. Esophageal temperature was
chosen because it is considered to be more reliable than
urinary bladder or tympanic temperature in reflecting
core body temperature [17,18]. The primary outcome
was a favorable neurological outcome, defined as best
CPC 1 (good recovery) or 2 (moderate disability) within
6 months after cardiac arrest. The secondary outcome
was all-cause mortality within 6 months of arrest.
Statistical analysis
We reported continuous variables as medians and 25%
to 75% interquartile ranges (IQRs) because they were
not generally normally distributed. Categorical variables
are reported as counts and percentages. The Mann-
Whitney U test was used to test the null hypothesis of
no difference in time to target temperature. To estimate
t h es i z eo ft h i se f f e c t ,w eu s e dl o g i s t i cr e g r e s s i o na n a l y -
sis, and favorable neurological outcome was the depen-
dent variable. We categorized the predictor time to
target temperature into tertiles of time from restoration
of spontaneous circulation to esophageal temperature of
not more than 34°C (<120, 120 to 220, and >220 min-
utes) because the assumption of a linear effect did not
hold when used as a continuous variable despite stan-
dard transformations. Potential confounders were identi-
fied by inspection after tabulating them along with
exposure and outcome. For formal hypothesis testing,
we used the Mann-Whitney U test, the Fisher exact test,
or the Pearson chi-square test as appropriate (Tables 1,
2, 3). To adjust the effect of time to target temperature
on neurological outcome to potential confounders, we
developed a multivariable logistic regression model. For
covariates, we included factors that were associated with
exposure as well as with outcome in our bivariate ana-
lyses but were not considered to be part of the causal
pathway from exposure to the outcome. These factors
included age, total amount of adrenaline needed to
achieve restoration of spontaneous circulation, tempera-
ture at beginning of cooling, cardiac arrest with ventri-
cular fibrillation, and nonperfusing ventricular
tachycardia as the initial cardiac rhythm (Table 4). Time
to restoration of spontaneous circulation, no-flow time,
and adrenaline dose were closely correlated to each
other, so we included only adrenaline dose as the most
robust variable in the model to cope with co-linearity.
The likelihood ratio test was used to assess deviations
from linearity and first-order interactions. The Hosmer-
Lemeshow goodness-of-fit statistic indicated a poor fit if
the resulting significance value was less than 0.05. We
calculated bootstrapped 95% confidence intervals. This
procedure was repeated for overall survival as the sec-
ondary outcome. Stata software (version 8.1; StataCorp
LP, College Station, TX, USA) was used to analyze the
data. A two-sided P value of less than 0.05 was generally
considered to be statistically significant.
Results
A total of 2,536 cardiac arrest patients were assessed;
1,948 of these patients were not cooled. Thus, 588
patients following the treatment algorithm were stu-
died; they included (a) a group of 285 (48%) patients
with favorable outcomes and (b) a group of 284 (48%)
survivors (Tables 1, 2, 3). All patients included in the
analysis were available for follow-up neurologic status
evaluation; 17 patients died during sedation, analgesia,
and paralysis. At baseline, the patients in the group
comparing morbidity were generally similar to the
group comparing mortality (Table 1). The methods
and strategies used for cooling were not different
between groups.
Table 2 Temperatures in degrees Celsius in correlation to morbidity and mortality
Best CPC 1-2
285 (48)
Best CPC 3-4
286 (49)
P value Survivors
284 (48)
Dead
304 (52)
P value
Tty 1st 35.3 (34.6-36) 35.4 (34.5-36.1) 0.92 35.2 (34.4-36) 35.5 (34.7-36.2) 0.05
Tty cool start 35.1 (34.1-35.8) 34.5 (33.6-35.7) 0.15 34.6 (33.8-35.4) 34.9 (33.9-35.9) 0.29
Tes 1st 35.9 (34.9-36.4) 35.2 (34.2-36) 0.05 35.7 (34.9-36.4) 35.2 (34.5-36.4) 0.32
Tes cool start 35.6 (34.8-36.2) 35.1 (34.2-35.9) <0.01 35.2 (34.5-36) 35.5 (34.6-36.1) 0.27
Tbl 1st 35.6 (34.9-36.2) 35.3 (34.6-35.9) 0.09 35.4 (34.7-36) 35.5 (34.9-36) 0.98
Tbl cool start 35.8 (34.9-36.5) 35.4 (34.6-36.1) <0.01 35.7 (34.6-36.3) 35.6 (34.7-36.3) 0.95
Temperature data between April 1995 and June 2008 were collected from 588 patients. The best cerebral performance category (CPC) achieved within 6 months
after cardiac arrest was used; this was not available in 17 patients who died during anesthesia. Data are presented as median (interquartile range). The two-
sample Wilcoxon rank-sum (Mann-Whitney) test and Fisher exact test, as appropriate, were used to compare variables in the surviving and dead groups and the
favorable and unfavorable neurologic outcome (CPC 1-2 versus 3-4) groups. Tbl, bladder temperature; Tes, esophageal temperature; Tty, tympanic temperature.
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were available from the tympanum (n = 313) than from
the esophagus (n = 102) or bladder (n = 179), and there
were no differences between groups (Table 2). The time
from restoration of spontaneous circulation until the
temperature recordings at cooling start in the tympa-
num (n =1 1 2 ) ,e s o p h a g u s( n = 177), and bladder (n =
276) did not differ significantly between the groups
(Table 2 and Figure 1). Time variables are presented in
Table 3.
We found 86% higher odds of a favorable neurological
outcome with an increase in each tertile of time to tar-
get temperature (adjusted odds ratio 1.86, 95% confi-
dence interval 1.03 to 3.38; P = 0.04) (Table 4). The
median time needed to achieve an esophageal tempera-
ture of less than 34°C was not associated with overall
Table 4 Multivariable logistic regression for favorable outcome
Odds ratio
(bootstrapped 95% confidence intervals)
P value
Time to target temperature
a - crude 1.69 (1.22-2.34) 0.002
Time to target temperature
a,b 1.86 (1.03-3.38) 0.04
Time to target temperature adjusted for
Age, years 0.95 (0.92-0.99) 0.01
Epinephrine, mg
c 0.70 (0.46-1.04) 0.08
Tbl cool start, °C
d 1.08 (0.71-1.63) 0.72
1st ECG, VF
e 2.54 (0.84-7.71) 0.10
aLinear effect for tertiles of time from restoration of spontaneous circulation (ROSC) to esophageal temperature of not more than 34°C (<120, 120 to 220, and
>220 minutes).
bHosmer-Lemeshow chi-squared = 2.67, P = 0.85, indicating good model fit. Temperature data between April 1995 and June 2008 were collected
from 588 patients.
cTotal amount of epinephrine in milligrams needed to achieve ROSC.
dBladder temperature in degrees Celsius at beginning of cooling.
eCardiac arrest with ventricular fibrillation or nonperfusing ventricular tachycardia as the initial cardiac rhythm on electrocardiogram.
Table 3 Minutes to target temperature in correlation to morbidity and mortality
Best CPC 1-2
285 (48)
Best CPC 3-4
286 (49)
P value Survivors
284 (48)
Dead
304 (52)
P value
ROSC to Tty 1st 29 (29-58) 29 (29-58) 0.23 29 (29-58) 29 (29-58) 0.59
ROSC to CoolStart 86 (43-144) 86 (58-115) 0.44 86 (58-130) 86 (43-130) 0.27
ROSC to Tty ≤34°C 144 (94-230) 144 (115-245) 0.77 151 (94-187) 130 (115-245) 0.56
ROSC to Tty ≤33°C 173 (130-230) 173 (122-230) 0.92 180 (130-216) 144 (130-245) 0.94
ROSC to Tes 1st 58 (29-58) 43 (29-65) 0.50 50 (29-58) 58 (29-86) 0.28
ROSC to CoolStart 86 (43-144) 86 (58-115) 0.44 86 (58-130) 86 (43-130) 0.27
ROSC toTes <34°C 209 (130-302) 158 (101-230) <0.01 202 (115-259) 158 (101-230) 0.57
ROSC to Tes <33°C 274 (202-389) 245 (144-374) 0.02 259 (166-367) 259 (158-389) 0.68
ROSC to Tbl 1st 58 (29-86) 58 (29-72) 0.29 58 (29-72) 58 (29-86) 0.62
ROSC to CoolStart 86 (43-144) 86 (58-115) 0.44 86 (58-130) 86 (43-130) 0.27
ROSC to Tbl <34°C 230 (158-360) 194 (115-288) <0.01 216 (144-288) 216 (144-346) 0.73
ROSC to Tbl <33°C 346 (245-504) 288 (187-418) <0.01 331 (245-475) 317 (216-446) 0.43
CoolStart to Tty <34°C 29 (0-43) 14 (0-115) 0.95 14 (0-43) 29 (0-115) 0.42
CoolStart to Tty <33°C 29 (14-72) 50 (14-137) 0.17 36 (14-101) 58 (29-130) 0.35
CoolStart to Tes <34°C 86 (43-144) 58 (29-115) 0.01 72 (43-130) 72 (29-144) 0.72
CoolStart to Tes <33°C 173 (86-274) 115 (58-245) 0.03 137 (72-245) 144 (72-245) 0.32
CoolStart to Tbl <34°C 115 (72-216) 86 (43-187) <0.01 101 (58-202) 101 (58-216) 0.98
CoolStart to Tbl <33°C 245 (144-418) 187 (101-317) 0.01 216 (115-389) 202 (101-331) 0.31
Temperature data between April 1995 and June 2008 were collected from 588 patients. The best cerebral performance category (CPC) achieved within 6 months
after cardiac arrest was used; this was not available in 17 patients who died during anesthesia. Data are presented as median (interquartile range). The two-
sample Wilcoxon rank-sum (Mann-Whitney) test was used to compare variables in the surviving and dead groups and the favorable and unfavorable neurologic
outcome (CPC 1-2 versus 3-4) groups. ROSC, restoration of spontaneous circulation; Tbl, bladder temperature; Tes, esophageal temperature; Tty, tympanic
temperature.
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survivors versus 158 minutes, 25% to 75% IQR 101 to
230 for nonsurvivors) (Table 3). Cooling methods used
are shown in Table 5.
Discussion
Our results show a strong relationship between the time
to target temperature and neurological outcome among
comatose patients in whom spontaneous circulation had
been restored after cardiac arrest and therapeutic
hypothermia was induced. A shorter time until systemic
cooling to an esophageal temperature below 34°C seems
to be able to predict unfavorable neurologic outcome. If
faster cooling is detrimental or patients with more
severe neurological damage show a faster cooling rate
has to be further evaluated.
Figure 1 Time to Target Temperature (T2TT) correlated to the best cerebral perforemance catergory (CPC). Temperature data between
April 1995 and June 2008 were collected from 588 patients. The best cerebral performance category achieved within 6 months after cardiac
arrest was used. A CPC of 1 indicates good cerebral performance (the patient is alert and has normal cerebral function). A CPC of 2 indicates
moderate disability (the patient is alert and has sufficient cerebral function to live independently and work part-time). Such patients might have
hemiplegia, seizures, ataxia, dysarthria, dysphasia or permanent memory loss, or other mental changes. A CPC of 3 indicates severe cerebral
disability (the patient is conscious but dependent on others for daily support because of impaired brain function). A CPC of 4 indicates a
vegetative state. Time is expressed in minutes from restoration of spontaneous circulation (ROSC) to hospital admission (admission), to first
monitored esophageal temperature (Tes 1st), to start of cooling (Cool Start), and to esophageal temperature (Tes) of less than 34°C, 33.5°C, and
33°C. Data are presented as median and interquaritle range from the 25th to the 75th percentile.
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observational, and descriptive single-center registry, but
the observers of temperature data were blinded to out-
come. All eligible patients may not have been cooled,
and many factors in regard to patient heat transfer are
not available, particularly in the beginning of post-arrest
cooling, which lies in the nature of implementing a new
therapeutic strategy. Even if a selection bias exists, the
time to target temperature over the years remains a fac-
tor independent from any bias. To analyze the effect of
the time to target temperature on morbidity and mortal-
ity, the cohort was evaluated independently in regard to
the best-ever-achieved CPC during the follow-up period
and in regard to survival. Therefore, it was necessary to
exclude the patients dying during sedation, analgesia,
and paralysis from the morbidity evaluation.
Though similar to those in other hypothermia trials,
the median time intervals in our study were still lengthy.
It took more than 80 minutes to commence cooling
therapy and around 3 hours to achieve the target tem-
perature. The time to initiation of cooling was not dif-
ferent between groups, showing that it does not
correlate with the time to target temperature. Therefore,
it appears that patients with a worse responsiveness to
cooling are those with a better outcome; however, this
cannot be proven without measuring heat transfer in a
prospective trial. Along the same lines, the data show
that esophageal temperatures at the beginning of cooling
were half a degree lower in patients with unfavorable
neurologic outcomes in comparison with those with
favorable neurologic outcomes. Thus, patients with
unfavorable neurologic outcomes could reach target
temperature more quickly. The delay in time to target
temperature could reflect a stronger natural homeostatic
central-nervous physiological response in those with
better outcomes; this might also explain the association
with improved outcome but not survival.
The standard for temperature monitoring in our
patients after cardiac arrest is to get the first tempera-
ture at the tympanum and thereafter as soon as possible
in the esophagus and bladder. By presenting the tem-
perature data from the three different sites separately,
we want to show that our findings are independently
the same (Table 2). This and the long time intervals to
initiation of cooling and achieving the target tempera-
ture justify basing the calculations only on the ones
Table 5 Cooling methods in correlation to morbidity and mortality
Survivors
284 (48)
Dead
304 (52)
P value Best CPC 1-2
285 (48)
Best CPC 3-4
286 (49)
P value
Cooling method
Endovascular 60 (21) 58 (19) 0.60 65 (23) 53 (17) 0.56
Head 10 (4) 7 (2) 0.54 6 (2) 11 (4) 0.13
Surface ice 43 (15) 36 (12) 0.62 29 (10) 50 (17) 0.01
Nasopharyngeal 7 (2) 7 (2) 0.95 5 (2) 9 (3) 0.18
IV 10 (4) 10 (3) 0.94 8 (3) 12 (4) 0.22
IV + endovascular 51 (18) 55 (18) 0.68 52 (18) 54 (18) 0.38
IV + surface air 5 (2) 9 (3) 0.29 5 (2) 9 (3) 0.18
IV + surface ice 6 (2) 8 (3) 0.57 6 (2) 8 (3) 0.39
IV + surface water 5 (2) 8 (3) 0.40 11 (4) 2 (1) 0.06
Surface air 39 (14) 65 (21) 0.05 53 (19) 51 (17) 0.54
Surface water 30 (11) 27 (9) 0.82 24 (8) 33 (11) 0.11
Surface waterbath 8 (3) 2 (1) 0.15 8 (3) 2 (1) 0.15
Other or mixed 13 (5) 9 (3) 0.48 13 (5) 9 (3) 0.73
Invasive cooling 155 (55) 160 (53) 161 (56) 154 (51)
Noninvasive cooling 129 (45) 144 (47) 0.68 124 (44) 149 (49) 0.19
Out-of-hospital cooling 25 (9) 23 (8) 19 (7) 29 (10)
In-hospital cooling 259 (91) 281 (92) 0.65 266 (93) 274 (90) 0.23
No IV cooling 207 (73) 214 (70) 203 (71) 218 (72)
IV cooling alone 10 (4) 10 (3) 8 (3) 12 (4)
IV+ cooling 67 (24) 80 (26) 0.75 74 (26) 73 (24) 0.68
Temperature data between April 1995 and June 2008 were collected from 588 patients. Data are presented as number (percentage). Fisher exact test, Pearson
chi-square test, and Wald test for comparing the cooling methods with ‘endovascular’ as reference were used to compare variables, such as favorable and
unfavorable neurologic outcome (cerebral performance category [CPC] 1-2 versus 3-4) groups, in the survivors and dead. IV, intravenous.
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initial bladder temperature for the multivariate analysis.
Even if temperatures at the beginning of cooling were
lower in patients with unfavorable neurologic outcomes,
the difference remains with 0.4°C marginal (Table 2)
and we have controlled for that variable and other con-
founders in our adjusted analysis (Table 3). However,
many known and possibly still unknown confounders
have not been taken care of and therefore our results
can be used only for hypothesis generating of future
trials necessary to answer this and many other questions
related to therapeutic hypothermia. In addition, the time
to target temperature from start of cooling, reflecting
the cooling rate, proved to be shorter in the group with
unfavorable neurologic outcomes. The reason for this
surprising result might be of an associative nature and
could be explained by the compromised thermoregula-
tion with cerebral insults [12,19]. The data are impor-
tant for those planning future prospective studies of
early versus delayed cooling.
The findings of the present study appear to be contra-
dictory to the notion that achieving mild therapeutic
hypothermia earlier and faster helps to reduce hypoxic
brain injury and favors a positive neurologic outcome
[3,20,21]. It is disappointing that no additional clinical
data of patients with cardiac arrest and cooling help to
explain that discrepancy. Therefore, all discussions of our
findings remain speculative and will not be able to
answer whether rapid cooling will cause more hemody-
namic changes or other cerebral effects that alter neuro-
logic outcome. Alternatively, it appears that sicker
patients lack homeostatic mechanisms to maintain nor-
mothermia and therefore cool faster. Unfortunately, the
question of how soon cooling should be initiated remains
unanswered and prospective human studies have yet to
define the ideal time to begin cooling patients [22].
Given the strong effect of therapeutic hypothermia
with a protocol chosen on the basis of experimental
data, there might be potential to further optimize the
treatment and gain an even better neurologic outcome
for patients after a global cerebral ischemic event
[20,23]. At present, hypothermia is initiated mainly in-
hospital and for arrests with cardiac etiology and a typi-
cal clinical presentation. However, there are no data to
support whether earlier and faster cooling, already
initiated in the out-of-hospital phase, may be better for
preserving neurologic function [24-26]. Further studies
should attempt to determine the time point at which
the initiation of therapeutic hypothermia becomes most
beneficial to patients who achieve restoration of sponta-
neous circulation following cardiac arrest [7,23]. Addi-
tional research is required to explore the best methods
for induction of therapeutic hypothermia, including the
most appropriate time and location of therapeutic
hypothermia initiation and the optimal means to induce
temperature reduction.
Conclusions
In comatose cardiac arrest patients treated with thera-
peutic hypothermia after return of spontaneous circu-
lation, a faster decline in body temperature to the 34°C
target appears to predict a less favorable neurologic
outcome. A faster decline in body temperature may
simply indicate a more severe ischemic insult with
resulting impairments in thermoregulation and thus
predicts a worse outcome. Nevertheless, prospective
studies should be conducted to confirm this observa-
tion and, in turn, address whether such a finding is
simply a marker for a more severe insult or whether
controlling the rate of cooling could favorably alter the
outcome.
Key messages
￿ In cardiac arrest managed with therapeutic
hypothermia after resuscitation, reaching the 34°C
target faster retrospectively predicts a poor neurolo-
gic outcome.
￿ A faster decline in body temperature may indicate
a more severe ischemic insult with impaired thermo-
regulation and thus predicts a worse outcome.
￿ Prospective studies should address whether this
finding is simply a marker for a more severe insult
or whether controlling the rate of cooling can favor-
ably alter outcome.
Abbreviations
CPC: cerebral performance category; IQR: interquartile range.
Acknowledgements
The following investigators participated in the Time to Target Temperature
(T2TT) study group of the Universitätsklinik für Notfallmedizin, Vienna, Austria
(temperature data collection, acquisition of data, analysis and interpretation
of data, involvement in revising the manuscript critically for important
intellectual content, and final approval of the version to be published):
Jasmin Arrich, Kewan Bayegan, Philip Eisenburger, Roman Fleischhackl,
Christoph Havel, Nina Holzer-Richling, Andreas Janata, Andreas Kliegel, Julia
Kofler, Klemens Köhler, Julia Koller, Angela Koppensteiner, Danica Krizanac,
Anton N Laggner, Heidrun Losert, Reinhard Malzer, Eva Riedmüller, Andreas
Schober, Waltarud Schörkhuber, Hanno Sendler (ethics committee
submission), Gottfried Sodeck, Peter Stratil, Thomas Uray, Marianne Vlcek,
Christian Wallmüller, Cosima Wandaller, and Andrea Zeiner-Schatzl.
We are indebted to the nurses and staff for their enthusiastic cooperation
and to the patients in the study for their trust and support. This study was
supported in part by grants from the Biomedicine and Health Programme
(BIOMED 2), implemented under the Fourth RTD Framework Programme
1994-1998 of the European Union (BMH4-CD-96-0667), the Austrian Ministry
of Science and Transport (GZ 5.550/12-Pr/4/95 and GZ 650.0251/2-IV/6/96),
and the Austrian Science Foundation (P11405-MED).
Authors’ contributions
WB, HH, and MHo contributed to the steering and writing committees, to
the conception and design, and to the analysis and interpretation of data.
MHa contributed to the writing committee and to the acquisition, analysis,
and interpretation of data. FS contributed to the steering and writing
Haugk et al. Critical Care 2011, 15:R101
http://ccforum.com/content/15/2/R101
Page 7 of 8committees, to the conception and design, and to the acquisition, analysis,
and interpretation of data. CT contributed to the writing committee and to
the acquisition of data. MU contributed to the temperature data collection,
to the writing committee, and to the acquisition and interpretation of data.
All authors were involved in drafting the manuscript or revising it critically
for important intellectual content. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 16 January 2011 Revised: 11 February 2011
Accepted: 25 March 2011 Published: 25 March 2011
References
1. Holzer M, Cerchiari E, Martens P, Roine R, Sterz F, Eisenburger P, Havel C,
Kofler J, Oschatz E, Rohrbach K, Scheinecker W, Schörkhuber W,
Behringer W, Zeiner A, Valentin A, De Meyer M, Takunen O, Tiainen M,
Hachimi-Idrissi S, Huyegens L, Fischer M, Walger P, Bartsch A, Födisch M,
Bonnizoli M, Pagni E, Kaff A, Schneider B, Müllner M: Mild therapeutic
hypothermia to improve the neurologic outcome after cardiac arrest. N
Engl J Med 2002, 346:549-556.
2. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G,
Smith K: Treatment of comatose survivors of out-of-hospital cardiac
arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
3. Wolff B, Machill K, Schumacher D, Schulzki I, Werner D: Early achievement
of mild therapeutic hypothermia and the neurologic outcome after
cardiac arrest. Int J Cardiol 2009, 133:223-228.
4. Kim F, Olsufka M, Longstreth WT Jr, Maynard C, Carlbom D, Deem S,
Kudenchuk P, Copass MK, Cobb LA: Pilot randomized clinical trial of
prehospital induction of mild hypothermia in out-of-hospital cardiac
arrest patients with a rapid infusion of 4 degrees C normal saline.
Circulation 2007, 115:3064-3070.
5. Arrich J: Clinical application of mild therapeutic hypothermia after
cardiac arrest. Crit Care Med 2007, 35:1041-1047.
6. Oksanen T, Pettila V, Hynynen M, Varpula T: Therapeutic hypothermia after
cardiac arrest: implementation and outcome in Finnish intensive care
units. Acta Anaesthesiol Scand 2007, 51:866-871.
7. Nielsen N, Hovdenes J, Nilsson F, Rubertsson S, Stammet P, Sunde K,
Valsson F, Wanscher M, Friberg H, Hypothermia Network: Outcome, timing
and adverse events in therapeutic hypothermia after out-of-hospital
cardiac arrest. Acta Anaesthesiol Scand 2009, 53:926-934.
8. Holzer M, Mullner M, Sterz F, Robak O, Kliegel A, Losert H, Sodeck G, Uray T,
Zeiner A, Laggner AN: Efficacy and safety of endovascular cooling after
cardiac arrest: cohort study and Bayesian approach. Stroke 2006,
37:1792-1797.
9. Uray T, Haugk M, Sterz F, Arrich J, Richling N, Janata A, Holzer M,
Behringer W: Surface cooling for rapid induction of mild hypothermia
after cardiac arrest: design determines efficacy. Acad Emerg Med 2010,
17:360-367.
10. Kliegel A, Janata A, Wandaller C, Uray T, Spiel A, Losert H, Kliegel M,
Holzer M, Haugk M, Sterz F, Laggner AN: Cold infusions alone are
effective for induction of therapeutic hypothermia but do not keep
patients cool after cardiac arrest. Resuscitation 2007, 73:46-53.
11. Haugk M, Sterz F, Grassberger M, Uray T, Kliegel A, Janata A, Richling N,
Herkner H, Laggner AN: Feasibility and efficacy of a new non-invasive
surface cooling device in post-resuscitation intensive care medicine.
Resuscitation 2007, 75:76-81.
12. Wandaller C, Holzer M, Sterz F, Wandaller J, Arrich J, Uray T, Laggner AN,
Herkner H: Head and neck cooling after cardiac arrest results in lower
jugular bulb than esophageal temperature. Am J Emerg Med 2009,
27:460-465.
13. Zeiner A, Holzer M, Sterz F, Behringer W, Schorkhuber W, Mullner M,
Frass M, Siostrzonek P, Ratheiser K, Kaff A, Laggner AN: Mild resuscitative
hypothermia to improve neurological outcome after cardiac arrest. A
clinical feasibility trial. Hypothermia After Cardiac Arrest (HACA) Study
Group. Stroke 2000, 31:86-94.
14. Holzer M: Targeted temperature management for comatose survivors of
cardiac arrest. N Engl J Med 2010, 363:1256-1264.
15. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett PJ, Becker L,
Bossaert L, Delooz HH, Dick WF, Eisenberg MS, Evans TR, Holmberg S,
Kerber R, Mullie A, Ornato JP, Sandoe E, Skulberg A, Tunstall-Pedoe H,
Swanson R, Thies WH: Recommended guidelines for uniform reporting of
data from out-of-hospital cardiac arrest: the Utstein Style. A statement
for health professionals from a task force of the American Heart
Association, the European Resuscitation Council, the Heart and Stroke
Foundation of Canada, and the Australian Resuscitation Council.
Circulation 1991, 84:960-975.
16. Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, Cassan P,
Coovadia A, D’Este K, Finn J, Halperin H, Handley A, Herlitz J, Hickey R,
Idris A, Kloeck W, Larkin GL, Mancini ME, Mason P, Mears G, Monsieurs K,
Montgomery W, Morley P, Nichol G, Nolan J, Okada K, Perlman J, Shuster M,
Steen PA, Sterz F, et al: Cardiac arrest and cardiopulmonary resuscitation
outcome reports: update and simplification of the Utstein templates for
resuscitation registries. A statement for healthcare professionals from a
task force of the international liaison committee on resuscitation
(American Heart Association, European Resuscitation Council, Australian
Resuscitation Council, New Zealand Resuscitation Council, Heart and
Stroke Foundation of Canada, InterAmerican Heart Foundation,
Resuscitation Council of Southern Africa). Resuscitation 2004, 63:233-249.
17. Lefrant JY, Muller L, de La Coussaye JE, Benbabaali M, Lebris C, Zeitoun N,
Mari C, Saïssi G, Ripart J, Eledjam JJ: Temperature measurement in
intensive care patients: comparison of urinary bladder, oesophageal,
rectal, axillary, and inguinal methods versus pulmonary artery core
method. Intensive Care Med 2003, 29:414-418.
18. Haugk M, Stratil P, Sterz F, Krizanac D, Testori C, Uray T, Losert UM, Sterz F:
Temperature monitored on the cuff surface of an endotracheal tube
reflects body temperature. Crit Care Med 2010, 38:1569-1574.
19. Sessler DI: Thermoregulatory defense mechanisms. Crit Care Med 2009, 37:
S203-S210.
20. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW, Callaway C,
Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT Jr,
Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP,
Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden Hoek T: Post-
cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and
prognostication. A consensus statement from the International Liaison
Committee on Resuscitation (American Heart Association, Australian and
New Zealand Council on Resuscitation, European Resuscitation Council,
Heart and Stroke Foundation of Canada, InterAmerican Heart
Foundation, Resuscitation Council of Asia, and the Resuscitation Council
of Southern Africa); the American Heart Association Emergency
Cardiovascular Care Committee; the Council on Cardiovascular Surgery
and Anesthesia; the Council on Cardiopulmonary, Perioperative, and
Critical Care; the Council on Clinical Cardiology; and the Stroke Council.
Circulation 2008, 118:2452-2483.
21. Howes D, Ohley W, Dorian P, Klock C, Freedman R, Schock R, Krizanac D,
Holzer M: Rapid induction of therapeutic hypothermia using convective-
immersion surface cooling: safety, efficacy and outcomes. Resuscitation
2010, 81:388-392.
22. Lyon RM, Richardson SE, Hay AW, Andrews PJ, Robertson CE, Clegg GR:
Esophageal temperature after out-of-hospital cardiac arrest: an
observational study. Resuscitation 2010, 81:867-871.
23. Majersik JJ, Silbergleit R, Meurer WJ, Brown DL, Lisabeth LD,
Morgenstern LB: Public health impact of full implementation of
therapeutic hypothermia after cardiac arrest. Resuscitation 2008,
77:189-194.
24. Coimbra C, Wieloch T: Moderate hypothermia mitigates neuronal
damage in the rat brain when initiated several hours following transient
cerebral ischemia. Acta Neuropathol 1994, 87:325-331.
25. Colbourne F, Corbett D, Zhao ZH, Yang J, Buchan AM: Prolonged but
delayed postischemic hypothermia: a long-term outcome study in the
rat middle cerebral artery occlusion model. J Cereb Blood Flow Metab
2000, 20:1702-1708.
26. Kuboyama K, Safar P, Radovsky A, Tisherman SA, Stezoski SW, Alexander H:
Delay in cooling negates the beneficial effect of mild resuscitative
cerebral hypothermia after cardiac arrest in dogs: a prospective,
randomized study [see comments]. Crit Care Med 1993, 21:1348-1358.
doi:10.1186/cc10116
Cite this article as: Haugk et al.: Relationship between time to target
temperature and outcome in patients treated with therapeutic
hypothermia after cardiac arrest. Critical Care 2011 15:R101.
Haugk et al. Critical Care 2011, 15:R101
http://ccforum.com/content/15/2/R101
Page 8 of 8